Related Experiment Videos
Neostigmine: an alternative treatment for constipation
1York Central Hospital, Richmond Hill, Ontario.
Dynamics (Pembroke, Ont.)
|April 20, 2005
Summary
Constipation is a common issue for amyotrophic lateral sclerosis (ALS) patients. Neostigmine shows promise in treating acute colonic pseudo-obstruction (ACPO) in ALS, offering new therapeutic avenues.
Area of Science:
- Neurology
- Gastroenterology
- Pharmacology
Background:
- Constipation is a frequent complication in amyotrophic lateral sclerosis (ALS), often worsening with disease progression.
- Gastrointestinal motility disturbances in ALS stem from the disease itself and reduced physical activity, not typically mechanical obstruction.
Observation:
- Acute colonic pseudo-obstruction (ACPO) presents as significant colon dilation without a physical blockage.
- A case study examined the application of neostigmine in managing ACPO within an ALS patient.
Findings:
- Neostigmine has emerged as a potentially effective treatment for ACPO.
- The study highlights the clinical use of neostigmine for ACPO in an ALS context.
Implications:
- Neostigmine offers a therapeutic option for ACPO in ALS patients.
- Understanding neostigmine's nursing implications is crucial for effective patient management and care.